INSP
NYSE
US
Inspire Medical Systems, Inc. Common Stock
$57,50
▲ +$1,05
(+1,86%)
Vol. 17K
Cap. mercato
$1.6B
P/E
11,2
ROE
21,1%
Margine
16,0%
Beta
0,83
52W
$48–$163
Consenso Wall Street
25 analisti · Apr 20264
Acquisto forte
7
Compra
14
Mantieni
0
Vendi
0
Vendita forte
44,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
LMAT
LeMaitre Vascular Inc
P/E 34,5
$1.8B
AORT
Artivion Inc
P/E 183,1
$1.8B
AXGN
AxoGen Inc
$1.5B
OMCL
Omnicell Inc
P/E 102,1
$2.0B
ATEC
Alphatec Holdings Inc
$3.1B
ENOV
Enovis Corp
$1.5B
ATRC
AtriCure Inc
$2.0B
PRCT
Procept Biorobotics Corp
$1.8B
BFLY
Butterfly Network Inc
$1.3B
TNDM
Tandem Diabetes Care Inc
$1.5B
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $0,89 | $1,62 | +$0,73 |
| Set 2025 | $-0,20 | $0,34 | +$0,54 |
| Giu 2025 | $0,21 | $0,45 | +$0,24 |
| Mar 2025 | $-0,25 | $0,10 | +$0,35 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $239.7M | $201.3M | $217.1M | $224.5M | $269.1M |
| Utile netto | $35.2M | $3.0M | -$3.6M | $9.9M | $136.1M |
Trend fondamentali
| Metrica | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 21.1% | 21.1% |
| P/E (TTM) | 10.62 | 11.18 |
| Net Margin | 15.9% | 15.9% |
| Gross Margin | 85.4% | 85.4% |
| D/E Ratio | — | — |
| Current Ratio | 6.08 | 6.08 |
Rapporti chiave
ROA (TTM)
17,9%
P/S (TTM)
1,78
P/B
3,4
EPS (TTM)
$4,97
CF/Share
$-1,03
Crescita ricavi 3A
+30,8%
52W High
$163,35
52W Low
$48,30
$48,30
Intervallo 52 settimane
$163,35
Salute finanziaria
Flusso di cassa libero
$41.8M
Debito netto
-$72.7M
Liquidità
$104.8M
Debito totale
$32.2M
Aggiornato al Dic 31, 2025
Як INSP виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка INSP vs аналоги Health Care
P/E
10,6
▼
66%
sotto
peer
(31,5)
vs Peer
vs Settore
Sottovalutato
P/S
1,7
▼
58%
sotto
peer
(4,0)
vs Peer
vs Settore
Sottovalutato
P/B
3,4
▼
24%
sotto
peer
(4,5)
vs Peer
vs Settore
Più costoso
Дивідендна дохідність
—
▼
0%
sotto
peer
(1,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість INSP vs аналоги Health Care
ROE
21,1%
▲
943%
sopra
peer
(2,0%)
vs Peer
vs Settore
Top livello
Net margin
16,0%
▲
718%
sopra
peer
(2,0%)
vs Peer
vs Settore
Top livello
Валова маржа
85,4%
▲
28%
sopra
peer
(66,9%)
vs Peer
vs Settore
Top livello
ROA
17,9%
▲
1606%
sopra
peer
(1,1%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя INSP vs аналоги Health Care
D/E ratio
—
▼
0%
sotto
peer
(27,1)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
6,1
▲
64%
sopra
peer
(3,7)
vs Peer
vs Settore
Liquidità forte
Beta
0,8
▼
12%
sotto
peer
(0,9)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів INSP
INSP
Mediana peer
Industria
INSP прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
INSP vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
6
Vendite
0
MANN MELISSA
Officer · Feb 20
award
15958 shs
PHILLIPS BRYAN K
General Counsel · Feb 20
award
26757 shs
HERBERT TIMOTHY P
Chief Executive Officer · Feb 20
award
71158 shs
RONDONI JOHN
Officer · Feb 20
award
18358 shs
WEATHERBY CARLTON
Officer · Feb 20
award
35791 shs
KELLY JASON P
Officer · Feb 20
award
15958 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 39,88%Blackrock Inc.
12,33%
$191.8M
Vanguard Group Inc
10,26%
$159.5M
Wellington Management Group…
7,68%
$119.4M
Deerfield Management Compan…
5,23%
$81.3M
Morgan Stanley
4,38%
$68.1M
Aggiornato al Dic 31, 2025